BBIO Insider Trading Activity and SEC Form 4 Filings
Trump's trades in BBIO
From his financial disclosures
$1K+
1 purchase
-
0 sales
Purchase
May 18, 2026
Reported 44d later
$1K - $15K
Many orders in these accounts are placed by the account manager.
BBIO insider trading summary
Over the past 12 months, insiders at BridgeBio Pharma, Inc. (BBIO) reported 135 sales worth $84.9M by 9 insiders and no open-market purchases on SEC Form 4. Net insider selling was $84.9M.
Latest BBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 30, 2026 | Maricel Apuli | Chief Accounting Officer | Sell | $146K (2,000 @ $72.85) |
| Sep 17, 2026 | Neil Kumar | Chief Executive Officer | Sell | $89K (1,279 @ $69.57) |
| Sep 17, 2026 | Neil Kumar | Chief Executive Officer | Sell | $602K (8,721 @ $69.01) |
| Aug 19, 2026 | Neil Kumar | Chief Executive Officer | Sell | $679K (8,100 @ $83.86) |
| Aug 19, 2026 | Neil Kumar | Chief Executive Officer | Sell | $152K (1,800 @ $84.69) |
| Aug 19, 2026 | Neil Kumar | Chief Executive Officer | Sell | $9K (100 @ $85.65) |
| Aug 18, 2026 | Neil Kumar | Chief Executive Officer | Sell | $154K (1,900 @ $81.15) |
| Aug 18, 2026 | Neil Kumar | Chief Executive Officer | Sell | $1.4M (17,279 @ $82.21) |
| Aug 18, 2026 | Neil Kumar | Chief Executive Officer | Sell | $100K (1,199 @ $83.77) |
| Aug 18, 2026 | Neil Kumar | Chief Executive Officer | Sell | $1.2M (14,602 @ $82.99) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.